| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.50M | -3,506 | |
| Dir | 35.0K | $793.0K | - | |
| Other | 29.1K | $659.2K | -1,332 | |
| 10% | 27.6K | $624.3K | - | |
| Dir | 25.4K | $574.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2024 | Teehan Brendan62 | EVP, COO, Head Of Commercial | Sell | 5,140 | $17.90 | $92,006.00 | -12.4% | -14.3% | -5.5% | |
| Mar 27, 2024 | Davis Stephen68 | CEO | Sell | 17,714 | $17.90 | $317,080.60 | -13.0% | -14.3% | -5.5% | |
| Mar 27, 2024 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sell | 5,434 | $17.90 | $97,268.60 | -17.2% | -14.3% | -5.5% | |
| Feb 26, 2024 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sale+OE | 772 | $24.67 | $19,045.24 | -3.5% | -41.7% | -26.6% | |
| Feb 26, 2024 | Teehan Brendan62 | EVP, COO, Head Of Commercial | Sale+OE | 624 | $24.67 | $15,394.08 | -1.9% | -41.7% | -26.6% | |
| Feb 26, 2024 | Kihara James62 | Principal Accounting Officer | Sale+OE | 474 | $24.67 | $11,693.58 | -4.0% | -41.7% | -26.6% | |
| Feb 26, 2024 | Davis Stephen68 | CEO | Sale+OE | 5,577 | $24.67 | $137,584.59 | -5.2% | -41.7% | -26.6% | |
| Jan 8, 2024 | Davis Stephen68 | CEO | Sale+OE | 3,732 | $29.96 | $111,810.72 | -3.7% | -40.9% | -42.3% | |
| Jan 8, 2024 | Teehan Brendan62 | EVP, COO, Head Of Commercial | Sale+OE | 731 | $29.96 | $21,900.76 | -2.3% | -40.9% | -42.3% | |
| Jan 8, 2024 | Kim Austin D.66 | EVP,General Counsel, Secretary | Sale+OE | 590 | $29.96 | $17,676.40 | -1.2% | -40.9% | -42.3% |